- 작성자 : ILIAS Biologics
- 작성일 : 21-01-05 13:52
- 조회 : 65회
5 Jan 2021
ILIAS Biologics appointed a new co-CEO from 1 January 2021
We are pleased to announce that Taejin Ham is appointed as Chief Executive Officer of ILIAS Biologics effective from 1 January 2021. Taejin joined ILIAS in 2020 as Chief Operating Officer and has since successfully redefined ILIAS's strategy and focus to position the company as a leading biotech in exosome-based therapeutics. Taejin brings over 20 years of business experience in diverse leadership roles at global biopharma companies, Eli Lilly and Celgene. Meanwhile, Dr. Chulhee Choi, the founder and chairman of ILIAS will continue to serve as co-CEO and Chief Scientific Officer and focus on strengthening ILIAS's R&D capability.
For more details, please read the full press release.